JAZZ
Jazz Pharmaceuticals Plc
NASDAQ · Healthcare · Biotechnology · IE
$234.66
+2.14%Margins
Gross margin
88.2%
EBITDA margin
24.8%
EBIT margin
20.3%
Net margin
4.4%
FCF margin
33.3%
4.9%
Return on equity
1.7%
Return on assets
9.7%
Return on invested capital
0.41x
Asset turnover
$1.7B
Cash from operations
$44
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Sep 1, 2026